Congenital Hemophilia A/B, von Willebrand's disease, Related Diseases, Hemophilia carrier
Conditions
Interventions
None listed
Sponsors
MATSUMOTO TAKESHI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Person corresponding to any of 1), 2), and 3), and 4) of the following items 1) Person with hemorrhagic diathesis due to congenital blood coagulation factor abnormalities 2) von Willebrand disease patient 3) Hemophilia carrier 4) Study subject who has provided consent for participation in the study using the informed consent form by him/herself or his/her legal representative; however, if it is judged that a minor study subject can express his/her intention, the consent to participate in the study should be obtained from the study subject him/herself using an informed assent form.
Exclusion criteria
Exclusion criteria: 1) Person with acquired hemorrhagic diathesis 2) Person with thrombotic diathesis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Actual use of each drug in bleeding disorders Information, etc. on patient demographics/treatment status/complications/efficacy/bleeding disorders-related tests Frequency and patient demographics of thromboembolic events and intracranial hemorrhage | — |
Contacts
Public ContactTAKESHI MATSUMOTO
Saitama Medical Center
Outcome results
None listed